NOVA:FRA
Novo Nordisk A/S
€37.72
arrow_upward
+0.59%(+0.22) 1દિ
17 નવે, 10:30:19 AM GMT+1 · EUR
search
બધા પ્રતીકો
| પ્રતીક | ભાવ | ફેરફાર | ફેરફાર %માં |
|---|
insights_autoNOVA માટે મુખ્ય જાણકારીઓ જનરેટ કરી રહ્યાં છીએ...
ખોલો
€38.02
ઉચ્ચ
€38.02
ઓછો
€37.36
માર્કેટ કૅપિટલાઇઝેશન
1.40 નિખર્વ
સરેરાશ વૉલ્યૂમ
661.00
વૉલ્યૂમ
240.00
52-અઠવાડિયામાં ઉચ્ચ
€54.80
52-અઠવાડિયામાં ન્યૂનતમ
€30.45
કર્મચારીઓની સંખ્યા
67 હજાર
ખોલો
€38.02
ઉચ્ચ
€38.02
ઓછો
€37.36
માર્કેટ કૅપિટલાઇઝેશન
1.40 નિખર્વ
સરેરાશ વૉલ્યૂમ
661.00
વૉલ્યૂમ
240.00
52-અઠવાડિયામાં ઉચ્ચ
€54.80
52-અઠવાડિયામાં ન્યૂનતમ
€30.45
કર્મચારીઓની સંખ્યા
67 હજાર
ન્યૂઝ સ્ટોરી
વેબ સૉર્સ અને ન્યૂઝ પાર્ટનર તરફથી
Traders Union
·
2 કલાક પહેલાં
Novo Nordisk stock trades flat as consolidation persists near $41.19 support
Financial Times
·
19 કલાક પહેલાં
Six-year-olds: Novo’s new frontier for weight-loss drugs
Yahoo Finance
·
19 કલાક પહેલાં
Anti-Obesity Drugs Market Companies Analysis 2027: Eli Lilly and Novo Nordisk Lead as Pfizer, Roche and Amgen Invest Billions to Challenge Them in a Market Headed for USD 64.96 Billion by 2035
Yahoo Finance
·
20 કલાક પહેલાં
Novo Nordisk A/S - share repurchase programme
પ્રોફાઇલ
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily obesity and diabetes medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 69,500 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe. Wikipedia
Novo Nordisk A/S વિશે
CEOમાઇક ડૌસ્ટડર
કર્મચારીઓ66.7 હજાર
સ્થાપના1923
હૅડક્વાર્ટરBagsværd, ડેનમાર્કનો કેપિટલ પ્રદેશ, ડેનમાર્ક
સેક્ટરHealth Care
ઉદ્યોગ-
વેબસાઇટnovonordisk.com